Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Surgical Oncology
|
January 1, 1993
Relief of metastatic biliary obstruction by stent placement: is it worthwhile?
I D Anderson, J M Manson, D F Martin, et al.
The British Journal of Surgery
|
November 15, 1997
Myths in management of colorectal malignancy
F Abbasakoor, J M Manson, A R Morgan, et al.
Archives of Toxicology
|
January 1, 1994
Embryotoxic effects of L-691,121, a class III antiarrhythmic agent, in rats
Y Ban, R Konishi, K Kawana, et al.
Toxicology
|
October 12, 1987
Developmental toxicity of halogenated acetonitriles: drinking water by-products of chlorine disinfection
M K Smith, E L George, H Zenick, et al.
Teratology
|
June 1, 1995
Evaluation of the reproductive and developmental toxicity of the AT1-selective angiotensin II receptor antagonist losartan in rats
S G Spence, M A Cukierski, J M Manson, et al.
Toxicology and Applied Pharmacology
|
June 30, 1988
Ovarian effects of SK&F 86002-A2 in the rat: site of action
R F Walker, L W Schwartz, T J Torphy, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
February 1, 1986
Evaluation of the reproductive toxicology of 2,4,6-trichlorophenol in male and female rats
K Blackburn, H Zenick, E Hope, et al.
Toxicology
|
October 1, 1979
Evaluation of teratogenicity and behavioral toxicity with inhalation exposure of maternal rats to trichloroethylene
M A Dorfmueller, S P Henne, R G York, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1983
The pharmacokinetics of cefotetan excretion in the unobstructed biliary tree
A W Owen, J M Manson, R A Yates, et al.
Teratology
|
June 1, 1995
Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats
S G Spence, H L Allen, M A Cukierski, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Surgical Oncology
|
January 1, 1993
Relief of metastatic biliary obstruction by stent placement: is it worthwhile?
I D Anderson, J M Manson, D F Martin, et al.
The British Journal of Surgery
|
November 15, 1997
Myths in management of colorectal malignancy
F Abbasakoor, J M Manson, A R Morgan, et al.
Archives of Toxicology
|
January 1, 1994
Embryotoxic effects of L-691,121, a class III antiarrhythmic agent, in rats
Y Ban, R Konishi, K Kawana, et al.
Toxicology
|
October 12, 1987
Developmental toxicity of halogenated acetonitriles: drinking water by-products of chlorine disinfection
M K Smith, E L George, H Zenick, et al.
Teratology
|
June 1, 1995
Evaluation of the reproductive and developmental toxicity of the AT1-selective angiotensin II receptor antagonist losartan in rats
S G Spence, M A Cukierski, J M Manson, et al.
Toxicology and Applied Pharmacology
|
June 30, 1988
Ovarian effects of SK&F 86002-A2 in the rat: site of action
R F Walker, L W Schwartz, T J Torphy, et al.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
|
February 1, 1986
Evaluation of the reproductive toxicology of 2,4,6-trichlorophenol in male and female rats
K Blackburn, H Zenick, E Hope, et al.
Toxicology
|
October 1, 1979
Evaluation of teratogenicity and behavioral toxicity with inhalation exposure of maternal rats to trichloroethylene
M A Dorfmueller, S P Henne, R G York, et al.
The Journal of Antimicrobial Chemotherapy
|
January 1, 1983
The pharmacokinetics of cefotetan excretion in the unobstructed biliary tree
A W Owen, J M Manson, R A Yates, et al.
Teratology
|
June 1, 1995
Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in rats
S G Spence, H L Allen, M A Cukierski, et al.
Page
of 7